Results 41 to 50 of about 1,360,810 (251)

Optic Pathway Glioma

open access: yes, 2017
Pediatric optic pathway gliomas share common clinicoradiographic characteristics and are typically World Health Organization grade I/II astrocytomas. Management of these tumors presents a therapeutic challenge based on host age as well as anatomic location.
Julie A. Bradley   +2 more
  +4 more sources

Overall Survival for the whole population with optic pathway glioma.

open access: yes, 2015
Overall Survival for the whole population with optic pathway glioma.
Jacques Grill (87832)   +8 more
core   +1 more source

(Pro)renin receptor is crucial for glioma development via the Wnt/β-catenin signaling pathway [PDF]

open access: yes, 2017
香川大学Kagawa University博士(医学)OBJECTIVE The (pro)renin receptor (PRR) plays an essential role in the early development of the central nervous system by activating the Wnt/β-catenin signaling pathway. The authors investigated the potential role of the PRR in
コウチ, マサアキ   +2 more
core   +1 more source

Acute post-partum vision loss due to pilocytic astrocytoma

open access: yesAmerican Journal of Ophthalmology Case Reports, 2020
Purpose: We report an unusual case of a thirty-three-year-old woman who presented with acute unilateral vision loss following pregnancy and was ultimately discovered to have a pilocytic astrocytoma of the optic nerve.
Natalie A. Homer   +5 more
doaj   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Torkildsen shunt as an option for hydrocephalus associated with optic pathway glioma

open access: yesArchives of Pediatric Neurosurgery, 2021
Hydrocephalus caused by optic pathway glioma (OPG) is most often treated with a ventriculoperitoneal shunt (VPS), but this treatment may present complications such as ascites. Hence, ventriculocisternal shunt is an option worth considering.
Aldo José F da Silva
doaj   +1 more source

From energy provision to protein synthesis: Tunnelling nanotubes as mediators of intercellular metabolic cooperation in cancer

open access: yesFEBS Open Bio, EarlyView.
The cytoskeleton‐mediated transport of mitochondria via tunnelling nanotubes restores respiration, increases ATP production, rescues cells from apoptosis, activates the AKT/mTOR signalling pathway, promotes cell migration and invasiveness, contributes to cancer progression and treatment resistance.
Stanislava Martínková, Jan Trnka
wiley   +1 more source

Novel treatments in optic pathway gliomas

open access: yesFrontiers in Ophthalmology, 2022
Optic pathway gliomas (OPG) are primary tumors of the optic nerve, chiasm, and/or tract that can be associated with neurofibromatosis type 1 (NF1). OPG generally have a benign histopathology, but a variable clinical course. Observation is generally recommended at initial diagnosis if vision is stable or normal for age, however, treatment may include ...
Maheshwari, Akash   +4 more
openaire   +2 more sources

Visual Field Outcomes in Optic Pathway Glioma After Bevacizumab Therapy

open access: yes, 2022
Systemic bevacizumab is a promising therapy for optic pathway glioma (OPG) radiographic tumor burden1, but little is known about its impact on visual function2,3.
Daniel Nelson; Benjamin Siegel; Tobey MacDonald; David Wolf; Jason Peragallo
core  

Spatial and Volumetric Characteristics of Glioblastoma: Associations With Clinical Presentation and Survival

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy